Mark Hopman

Chief Commercial Officer, Beta Bionics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$1.6M

Companies

Latest trade

Oct 14, 2026

Companies

Beta Bionics, Inc.Chief Commercial Officer −$1.6M

Trades

BBNX Sold 775 shares at $17.35 · planned $0.0M Oct 14

BBNX Sold 370 shares at $18.96 · planned $0.0M Oct 1

BBNX Sold 30,779 shares at $20.13 · planned $0.6M Sep 16

BBNX Sold 775 shares at $15.52 · planned $0.0M Sep 14

BBNX Sold 36,870 shares at $18.46 · planned $0.7M Sep 9

BBNX Sold 5,327 shares at $19.11 $0.1M Sep 2

BBNX Sold 1,258 shares at $15.01 · planned $0.0M Jun 24

BBNX Sold 275 shares at $12.31 · planned $0.0M Jun 4

BBNX Sold 5,329 shares at $12.61 $0.1M Jun 2

BBNX Sold 353 shares at $11.57 · planned $0.0M Mar 4

BBNX Sold 834 shares at $12.36 $0.0M Mar 2

BBNX Sold 2,061 shares at $30.66 · planned $0.1M Dec 4

BBNX Sold 856 shares at $29.34 · planned $0.0M Dec 2

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.